Pretax income is the income that a company earns before paying income taxes. VolitionRX's pretax income for the
three
months ended in Dec. 2023 was $-8.80 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-35.68 Mil.
VolitionRX's pretax margin was -3,606.56%.
During the past 13 years, VolitionRX's highest Pretax Margin was -4603.48%. The lowest was -156915.38%. And the median was -29988.89%.
VolitionRX Pre-Tax Income Historical Data
The historical data trend for VolitionRX's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of VolitionRX's Pre-Tax Income
For the Diagnostics & Research subindustry, VolitionRX's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VolitionRX's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, VolitionRX's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where VolitionRX's Pre-Tax Income falls into.
VolitionRX Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
VolitionRX's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-35.68 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VolitionRX (AMEX:VNRX) Pre-Tax Income Explanation
VolitionRX's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, VolitionRX's highest Pretax Margin was -4603.48%. The lowest was -156915.38%. And the median was -29988.89%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VolitionRX Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of VolitionRX's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VNRX has been successfully added to your 